Anthony Cousien, Viet Chi Tran, Sylvie Deuffic‐Burban, Marie Jauffret‐Roustide, Jean‐Stéphane Dhersin, Yazdan Yazdanpanah – 21 September 2015 – Hepatitis C virus (HCV) seroprevalence remains high in people who inject drug (PWID) populations, often above 60%. Highly effective direct‐acting antiviral (DAA) regimens (90% efficacy) are becoming available for HCV treatment. This therapeutic revolution raises the possibility of eliminating HCV from this population. However, for this, an effective cascade of care is required.

Keito Yoshimura, Takeshi Okanoue, Hayao Ebise, Tsuyoshi Iwasaki, Masayuki Mizuno, Toshihide Shima, Junji Ichihara, Kazuto Yamazaki – 21 September 2015 – It is important that patients with nonalcoholic steatohepatitis (NASH) are diagnosed and treated early to prevent serious complications, such as liver cirrhosis or hepatocellular carcinoma. However, current methods for NASH diagnosis are invasive given that they rely on liver biopsy, making early diagnosis difficult. In this study, we developed novel noninvasive markers for the diagnosis of NASH and NASH‐related fibrosis.

Evangelos Cholongitas, Nikolaos Antoniadis, Ioannis Goulis, Ioannis Fouzas, Themistoklis Vasiliadis, Evangelos Akriviadis, Vasilios Papanikolaou – 21 September 2015

Anne T. Schneider, Jérémie Gautheron, Frank Tacke, Mihael Vucur, Tom Luedde – 21 September 2015

Vivek Vij, Kausar Makki, Vishal Kumar Chorasiya, Gaurav Sood, Ashish Singhal, Puneet Dargan – 21 September 2015 – Biliary complications are regarded as the Achilles' heel of liver transplantation, especially for living donor liver transplantation (LDLT) due to smaller, multiple ducts and difficult ductal anatomy. Overall biliary complications reported in most series are between 10% and 30%. This study describes our modified technique of biliary anastomosis and its effects on incidence of biliary complications.

Jia‐Feng Wu, Yu‐Chun Chiu, Kai‐Chi Chang, Huey‐Ling Chen, Yen‐Hsuan Ni, Hong‐Yuan Hsu, Mei‐Hwei Chang – 21 September 2015 – Hepatitis B e antigen (HBeAg)‐negative hepatitis is a clinical indicator of poor outcome for chronic hepatitis B viral (HBV) infection. This long‐term prospective cohort study aimed to elucidate the predictors of developing HBeAg‐negative hepatitis in chronic HBV‐infected subjects followed from childhood to adulthood. We followed 434 HBeAg‐positive chronic HBV‐infected patients from a median age of 7.22 years (interquartile range 4.31‐10.21 years).

Lily Dara, Neil Kaplowitz – 21 September 2015

Ulrich Beuers, M. Eric Gershwin, Robert G. Gish, Pietro Invernizzi, David E.J. Jones, Keith Lindor, Xiong Ma, Ian R. Mackay, Albert Parés, Atsushi Tanaka, John M. Vierling, Raoul Poupon – 15 September 2015

Paolo Angeli, Salvatore Piano – 15 September 2015

Esteban Halac, Marcelo Dip, Emilio Quiñonez, Fernando Alvarez, Johana Leiva Espinoza, Pablo Romero, Franco Nievas, Rafael Maurette, Carlos Luque, Daniel Matus, Paz Surraco, Martin Fauda, Lucas McCormack, Francisco J. Mattera, Gabriel Gondolesi, Oscar Imventarza – 15 September 2015 – Grafts from split livers (SLs) constitute an accepted approach to expand the donor pool. Over the last 5 years, most Argentinean centers have shown significant interest in increasing the use of this technique.